David Scadden

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ William Cook, as Attorney-in-fact for David Scadden
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David Scadden

Form 4 holding Director

Carisma Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
38,700
Estimated value
Report date
01 Jul 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Editas Medicine, Inc.

Security class
Stock Option (right to buy)
Shares / value
37,500
Estimated value
Report date
06 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Magenta Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
28 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David Scadden

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .